Ahmed M. Abdelhady, MSc, PhD (he/him/his)

Director Clinical Pharmacology
Intellia Therapeutics

Poster(s):

• PII-121 - IMPLEMENTATION OF QUANTITATIVE SYSTEMS PHARMACOLOGY MODELING IN TRANSLATION AND DOSE SELECTION FOR FIRST-IN-HUMAN PHASE 1/2 CLINICAL STUDY OF NTLA-2002 IN THE TREATMENT OF HEREDITARY ANGIOEDEMA
  Thursday, March 28, 2024

  5:00 PM – 6:30 PM MDT